Verapamil Hydrochloride
Product Images NDC 71610-377

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Verapamil Hydrochloride (NDC 71610-377). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 240 mg (71610 0377 60)

Label for VERAPAMIL HYDROCHLORIDE ER, USP 240 mg extended-release tablets. The label states a quantity of 90 tablets, manufactured by Cadila Pharmaceuticals Limited in Ahmedabad, India, and repackaged by Aphena Pharma Solutions - Tennessee, LLC in Cookeville, TN. Storage instructions indicate maintaining controlled room temperature between 68-77°F and keeping the product in a tightly light-resistant container, out of reach of children.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Chemical Structure (Verapamil 01)

Chemical structure of verapamil hydrochloride showing its molecular arrangement with methoxy groups on aromatic rings and a nitrile group, corresponding to the active ingredient in VERAPAMIL HYDROCHLORIDE by Aphena Pharma Solutions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.